A case of Carney triad complicated by renal cell carcinoma and a germline SDHA pathogenic variant.


Journal

Endocrinology, diabetes & metabolism case reports
ISSN: 2052-0573
Titre abrégé: Endocrinol Diabetes Metab Case Rep
Pays: England
ID NLM: 101618943

Informations de publication

Date de publication:
28 Mar 2021
Historique:
received: 23 02 2021
accepted: 02 03 2021
pubmed: 12 4 2021
medline: 12 4 2021
entrez: 11 4 2021
Statut: aheadofprint

Résumé

Succinate dehydrogenase deficiency has been associated with several neoplasias, including renal cell carcinoma (RCC) and those associated with hereditary paraganglioma (PGL)/ pheochromocytoma (PHEO) syndromes, Carney dyad, and Carney triad. Carney triad is a rare multitumoral syndrome characterized by co-existing PGL, gastrointestinal stromal tumor (GIST), and pulmonary chondroma (CHO). We report a case of a 57-year-old male who presented with para-aortic and gastroesophogeal masses, and a right renal superior pole lesion, which were classified as multiple PGLs, a GIST, and a clear cell renal carcinoma, respectively, on pathology following surgical resection. Additionally, a CHO was diagnosed radiologically, although no biopsy was performed. A diagnosis of Carney triad was made. SDHB immunohistochemical staining was negative for the PGL and the GIST, indicating SDH-deficiency. Interestingly, the renal cell carcinoma (RCC) stained positive for both SDHB and SDHA. Subsequent genetic screening of SDH subunit genes revealed a germline inactivating heterozygous SDHA pathogenic variant (c.91 C>T, p.R31X). Loss of heterozygosity was not detected at the tumor level for the RCC, which likely indicated the SDHA variant would not be causative of the RCC, but could still predispose to the development of neoplasias. To the knowledge of the authors this is the first reported case of an SDHA pathogenic variant in a patient with Carney triad complicated by RCC. The succinate dehydrogenase enzyme is encoded by four subunit genes (SDHA, SDHB, SDHC, and SDHD; collectively referred to as SDHx), which have been implicated in several neoplasias and are classified as tumor suppressor genes. Carney triad is a rare multiple-neoplasia syndrome presenting as an association of PGLs, GISTs, and CHOs. Carney triad is most commonly associated with hypermethylation of SDHC as demonstrated in tumor tissue, but approximately 10% of cases are due to pathogenic SDHx variants. Although SDHB pathogenic variants are most commonly reported in SDH-deficient renal cell carcinoma, SDHA disease-causing variants have been reported in rare cases.

Identifiants

pubmed: 33839693
doi: 10.1530/EDM-20-0170
pii: EDM200170
pmc: PMC8052566
doi:
pii:

Types de publication

Journal Article

Langues

eng

Auteurs

Rachel Wurth (R)

Section on Endocrinology and Genetics, National Institutes of Health, Bethesda, Maryland, USA.

Abhishek Jha (A)

Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Crystal Kamilaris (C)

Section on Endocrinology and Genetics, National Institutes of Health, Bethesda, Maryland, USA.

Anthony J Gill (AJ)

Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital St Leonards NSW 2065 Australian and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.

Nicola Poplawski (N)

Adult Genetics Unit, Royal Adelaide Hospital.
Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.

Paraskevi Xekouki (P)

Section on Endocrinology and Genetics, National Institutes of Health, Bethesda, Maryland, USA.

Martha M Quezado (MM)

Laboratory of Pathology Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Karel Pacak (K)

Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Constantine A Stratakis (CA)

Section on Endocrinology and Genetics, National Institutes of Health, Bethesda, Maryland, USA.

Fady Hannah-Shmouni (F)

Section on Endocrinology and Genetics, National Institutes of Health, Bethesda, Maryland, USA.

Classifications MeSH